Testing Apremilast to Help Treat Alcohol Use Disorder

This study is for adults age 21 or older who have alcohol use disorder (AUD). It tests whether a medicine called Apremilast can help reduce alcohol cravings compared to a placebo, a pill that looks the same but has no medicine.


Why this Research Matters

AUD is one of the most common substance use problems in the world. It is a medical condition where someone has trouble stopping or controlling their drinking, even when it causes problems at home, work, school, or with their health. Right now, there are only a few medications to treat AUD, so more research is needed to find safe and effective options. If you join the study, your first visit will take about 2.5 to 3 hours. During this visit, you will have a physical exam and a heart test, give blood and urine samples, take a breath test for alcohol, and fill out surveys. If you qualify, you will be randomly placed into one of three groups, like flipping a coin. You will get either 60 mg of Apremilast, 90 mg of Apremilast, or a placebo, which is a pill that looks the same but has no active medicine. After joining a group, you will continue with similar tests and questionnaires during the study. The study lasts up to 10 weeks. You will visit the clinic at the CU Anschutz campus about 7 times, with maybe a few extra visits. Two weeks after your last visit, you will have a follow-up phone call. There is no cost to join the study. You can earn up to $605 for completing all study visits.


Who can Participate

Adult

You may be able to join the study if you are 21 or older, drink alcohol regularly, have AUD, and want help to cut down or stop drinking.


Study ID

Protocol Number: 25-2638

More information available at ClinicalTrials.gov: NCT07325266


Compensation Information

Compensation
Study Payment: Compensation provided.

Meet the Team

Image of Principal Investigator

Joseph Schacht, PhD

Principal Investigator